Novartis Announces EC Approvals for Cosentyx to Treat Patients with Ankylosing Spondylitis, Psoriatic Arthritis
November 23, 2015 at 04:12 AM EST
Novartis (NYSE: NVS) announced today that the European Commission (EC) has approved Cosentyx® (secukinumab) for the treatment of people ...